Normal, intact rats generally show transient elevations of pituitary-adrenal hormones in response to acute stress. The immediate hypersecretion, followed by return to baseline levels after approximately 2 h, is believed to be due to CRF of median eminence origin (ME-CRF). Lesioned rats, on the other hand, do not usually exhibit an immediate response, but under certain conditions show a delayed hypersecretion of pituitary-adrenal hormones 2–4 h later. From our previous studies it has been demonstrated that the delayed response of lesioned rats is due to release of tissue-CRF. To examine the relationship between ME-CRF and tissue-CRF, groups of lesioned animals were subjected to the stress of plasma injection or laparotomy. Both stimuli produced a delayed hypersecretion of corticosterone 2–8 h later. When, however, ME-CRF or ACTH was administered at the time of application of the stress, the expected delayed response was significantly suppressed and plasma corticosterone levels approached baseline values. To determine how the delayed response was suppressed, one group of lesioned-hypophysectomized donor rats was subjected to laparotomy stress and 5 h later the blood from these animals was assayed for tissue-CRF. Another group of lesioned-hypophysectomized rats was not only subjected to the laparotomy stress but also injected with ACTH at the same time and then tested for blood CRF activity 5 h later. Prior administration of ACTH caused a significant reduction in the tissue-CRF levels in the peripheral blood. Therefore it appears that suppression of the delayed response by ME extract

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.